title: Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
abstract: Approximately 10% to 15% of human cancers lack detectable telomerase activity, and a subset of these maintain telomere lengths by the telomerase-independent telomere maintenance mechanism termed alternative lengthening of telomeres (ALT). The ALT phenotype, relatively common in subtypes of sarcomas and astrocytomas, has rarely been reported in epithelial malignancies. However, the prevalence of ALT has not been thoroughly assessed across all cancer types. We therefore comprehensively surveyed the ALT phenotype in a broad range of human cancers. In total, two independent sets comprising 6110 primary tumors from 94 different cancer subtypes, 541 benign neoplasms, and 264 normal tissue samples were assessed by combined telomere-specific fluorescence in situ hybridization and immunofluorescence labeling for PML protein. Overall, ALT was observed in 3.73% (228/6110) of all tumor specimens, but was not observed in benign neoplasms or normal tissues. This is the first report of ALT in carcinomas arising from the bladder, cervix, endometrium, esophagus, gallbladder, kidney, liver, and lung. Additionally, this is the first report of ALT in medulloblastomas, oligodendrogliomas, meningiomas, schwannomas, and pediatric glioblastoma multiformes. Previous studies have shown associations between ALT status and prognosis in some tumor types; thus, further studies are warranted to assess the potential prognostic significance and unique biology of ALT-positive tumors. These findings may have therapeutic consequences, because ALT-positive cancers are predicted to be resistant to anti-telomerase therapies.
authors: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. ameeker1@jhmi.edu
authors: Christopher M
authors: CM
authors: Heaphy
authors: Andrea P
authors: AP
authors: Subhawong
authors: Seung-Mo
authors: SM
authors: Hong
authors: Michael G
authors: MG
authors: Goggins
authors: Elizabeth A
authors: EA
authors: Montgomery
authors: Edward
authors: E
authors: Gabrielson
authors: George J
authors: GJ
authors: Netto
authors: Jonathan I
authors: JI
authors: Epstein
authors: Tamara L
authors: TL
authors: Lotan
authors: William H
authors: WH
authors: Westra
authors: Ie-Ming
authors: IeM
authors: Shih
authors: Christine A
authors: CA
authors: Iacobuzio-Donahue
authors: Anirban
authors: A
authors: Maitra
authors: Qing K
authors: QK
authors: Li
authors: Charles G
authors: CG
authors: Eberhart
authors: Janis M
authors: JM
authors: Taube
authors: Dinesh
authors: D
authors: Rakheja
authors: Robert J
authors: RJ
authors: Kurman
authors: T C
authors: TC
authors: Wu
authors: Richard B
authors: RB
authors: Roden
authors: Pedram
authors: P
authors: Argani
authors: Angelo M
authors: AM
authors: De Marzo
authors: Luigi
authors: L
authors: Terracciano
authors: Michael
authors: M
authors: Torbenson
authors: Alan K
authors: AK
authors: Meeker
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000145:classification* / Q000473:pathology*; D016615:Telomere / Q000378:metabolism*; D059505:Telomere Homeostasis